title: NMO spectrum presenting as partial myelitis.
authors.forename: Melissa R
authors.initials: MR
authors.lastname: Ortega
authors.forename: Leticia
authors.initials: L
authors.lastname: Tornes
authors.forename: Kottil W
authors.initials: KW
authors.lastname: Rammohan
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D006930:Hyperalgesia / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D018908:Muscle Weakness / Q000209:etiology; D009188:Myelitis, Transverse / Q000175:diagnosis* / Q000503:physiopathology; D009471:Neuromyelitis Optica / Q000175:diagnosis* / Q000503:physiopathology; D013116:Spinal Cord / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D008775:Methylprednisolone